Search

everythinglearnresearchcommunity

for

Search:↓

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

The research developed new fortilin protein constructs for potential heart disease treatments.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Ixekizumab effectively treats generalized pustular psoriasis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Reducing gefitinib dosage improved hair loss, but scarring remained.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Afatinib often causes skin problems that need proactive management.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.